1.
Low dose cytarabine-induced posterior reversible encepalopathy syndrome with atypical features. Ann Med Res [Internet]. 2025 Dec. 25 [cited 2026 Jan. 8];32(12):574-5. Available from: http://annalsmedres.org/index.php/aomr/article/view/4897